Please try another search
For the nine months ended 30 June 2013, CompuMed, Inc. revenues increased 10% to $1.4M. Net loss applicable to common stockholders increased 66% to $116K. Revenues reflect ECG Product and Supplies increase of 33% to $265K, ECG services increase of 6% to $1.1M, OsteoGram and Osteometer sales and servi increase of 3% to $74K. Higher net loss reflects General and administrative expenses increase of 9% to $502K (expense).
Period Ending: | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 |
---|---|---|---|---|
Total Revenue | 0.55 | 0.84 | 0.41 | 0.39 |
Gross Profit | 0.26 | 0.42 | 0.21 | 0.22 |
Operating Income | 0.03 | -0.12 | -0.1 | -0.04 |
Net Income | 0.01 | -0.13 | -0.09 | -0.03 |
Period Ending: | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 |
---|---|---|---|---|
Total Assets | 0.9 | 0.78 | 0.78 | 0.7 |
Total Liabilities | 0.79 | 0.74 | 0.8 | 0.63 |
Total Equity | 0.11 | 0.04 | -0.01 | 0.07 |
Period Ending: | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -0.02 | -0.12 | -0.01 | 0.04 |
Cash From Investing Activities | -0 | 0.04 | 0 | -0.03 |
Cash From Financing Activities | 0.07 | 0.1 | 0.04 | -0.06 |
Net Change in Cash | 0.04 | 0.02 | 0.03 | -0.04 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review